REGULATORY

• PMDA Reviewing Safety Risks for Plaquenil, Relumina
  August 3, 2020

• PMDA Provided Preliminary Info on MID-NET Use for Free in “Just Under 10 Cases”: Official
  July 31, 2020

• MHLW Finds 57 Suspected Violations in Drug Detailing Activities in FY2019
  July 30, 2020

• AMED’s Drug Discovery Library under CiCLE Program Ready to Start Operations
  July 30, 2020

• AMED Selects 2 Anti-COVID-19 Projects under CiCLE Grant Program
  July 30, 2020

• HPV Vaccines Clinically Significant in Japan, PMDA Says in Silgard 9 Review Report
  July 28, 2020

• Dexamethasone Added to MHLW’s COVID-19 Guide
  July 27, 2020

• Chuikyo OKs Plan for September Drug Price Survey, Smaller Coverage amid COVID-19
  July 22, 2020

• Reinstate “Active Recommendation” for HPV Vaccines: LDP Lawmakers’ League
  July 22, 2020

• Label Revisions Ordered for Iopamiron, 5 Other Contrast Media
  July 22, 2020

• September Drug Price Survey Likely as MHLW to Keep Its Proposal Unchanged
  July 21, 2020

• Kadcyla, Keytruda, Imfinzi in Line for Label Expansion in August
  July 20, 2020

• 2020 Policy Blueprint Restresses Efforts on COVID-19 Meds/Vaccines; Drug Price Survey Up for Discussion on July 22
  July 20, 2020

• Japan Might Tap Coronavirus Emergency Reserve for Vaccines
  July 17, 2020

• Japan Govt Adopts 2020 Honebuto Policy, Drug Price Survey to Be Conducted This Autumn
  July 17, 2020

• Otsuka Pharmaceutical Factory’s Infusion Solution in Line for September Approval
  July 16, 2020

• Japan Govt to Push Ahead with Off-Year Survey, Considering COVID-19 Impact to Decide on Re-Pricing
  July 16, 2020

• Japan Govt Maps Out Action Strategy for Regulatory Harmonization in Asia
  July 15, 2020

• Health Minister Asks Makers to Boost Syringe, Needle Production for Coronavirus Vaccines
  July 15, 2020

• Coronavirus-Neutralizing Antibodies Detected in Japan for 1st Time
  July 15, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• …
• Next ›
• 最終 »